Russell Investments Group
COLL icon

Russell Investments Group’s Collegium Pharmaceutical COLL Stock Holding History

Russell Investments Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$488K Buy
13,473
+6,002
+80% +$205K ﹤0.01% 2798
2026
Q1 		$247K Sell
7,471
-4,257
-36% -$180K ﹤0.01% 2782
2025
Q4 		$543K Buy
11,728
+5,328
+83% +$223K ﹤0.01% 2460
2025
Q3 		$224K Buy
6,400
+5,189
+428% +$180K ﹤0.01% 2773
2025
Q2 		$35.8K Sell
1,211
-1,381
-53% -$39.4K ﹤0.01% 3059
2025
Q1 		$77.4K Sell
2,592
-11,057
-81% -$338K ﹤0.01% 2810
2024
Q4 		$391K Sell
13,649
-6,223
-31% -$206K ﹤0.01% 2358
2024
Q3 		$768K Buy
19,872
+6,276
+46% +$224K ﹤0.01% 2130
2024
Q2 		$438K Sell
13,596
-19,488
-59% -$676K ﹤0.01% 2245
2024
Q1 		$1.28M Buy
33,084
+1,011
+3% +$35.4K ﹤0.01% 1877
2023
Q4 		$987K Buy
32,073
+6,796
+27% +$170K ﹤0.01% 1974
2023
Q3 		$565K Buy
25,277
+6,784
+37% +$155K ﹤0.01% 2186
2023
Q2 		$397K Sell
18,493
-87,503
-83% -$1.99M ﹤0.01% 2293
2023
Q1 		$2.54M Buy
105,996
+79,622
+302% +$2.11M 0.01% 1433
2022
Q4 		$612K Buy
26,374
+16,966
+180% +$342K ﹤0.01% 2203
2022
Q3 		$150K Sell
9,408
-88,968
-90% -$1.57M ﹤0.01% 2602
2022
Q2 		$1.74M Sell
98,376
-10,427
-10% -$175K ﹤0.01% 1669
2022
Q1 		$2.21M Buy
+108,803
New +$2.06M ﹤0.01% 1591
2020
Q2 		– Sell
-80,178
Closed -$1.32M – 3137
2020
Q1 		$1.32M Buy
+80,178
New +$1.65M ﹤0.01% 1704
2019
Q2 		– Sell
-4,253
Closed -$67K – 2873
2019
Q1 		$67K Buy
+4,253
New +$68.1K ﹤0.01% 2776
2018
Q3 		– Sell
-155,929
Closed -$3.72M – 2956
2018
Q2 		$3.72M Sell
155,929
-3,984
-2% -$98K 0.01% 1426
2018
Q1 		$4.09M Buy
+159,913
New +$3.81M 0.01% 1469

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Russell Investments Group's COLL Position: Q2 2026 in Review

Russell Investments Group increased its Collegium Pharmaceutical (COLL) stake by 80% in Q2 2026, buying an estimated $205K and bringing the position to 13,473 shares worth $488K. The position accounts for ﹤0.01% of the portfolio, ranked #2798.

Russell Investments Group first reported a position in COLL in Q1 2018 and has held it in 22 quarters since. The position peaked at $4.09M in Q1 2018. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Russell Investments Group held 13,473 shares of Collegium Pharmaceutical worth $488K as of Q2 2026.
  • Russell Investments Group bought 6,002 Collegium Pharmaceutical shares in Q2 2026, an estimated $205K.
  • Collegium Pharmaceutical made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2798 holding.
  • Russell Investments Group first reported a position in Collegium Pharmaceutical in Q1 2018 and has held it in 22 quarters since.
  • Russell Investments Group's Collegium Pharmaceutical position peaked at $4.09M in Q1 2018.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.